Skip to content
Volume 108 - Issue 6

Note: Venerunt, Viderunt, Vicerunt Venue: How TC Heartland and In re Cray Have Conquered Patent Venue for Corporate Defendants and How Congress Can Balance the Scales of Patent Venue Justice

By Peter Estall. Full text here. Venue in patent infringement suits is governed not by the general venue statute, 28 U.S.C. § 1391, but by its own statute, 28 U.S.C. § 1400(b). Section 1400(b) provides for venue in either the district the defendant “resides” or where it has “a regular and established place of business.” Until the…

Continue Reading

Note: Coerced into Health: Workplace Wellness Programs and Their Threat to Genetic Privacy

By Julia Wolfe. Full text here. Abstract: “Workplace wellness programs have proliferated in recent years, thanks to a convergence of forces: the Affordable Care Act, steeply rising medical costs, and high rates of obesity and chronic illness. While aiming to lower healthcare costs and increase employee productivity, these initiatives raise troubling privacy concerns, specifically in…

Continue Reading

Note: The Ghost of Salary Past: Why Salary History Inquiries Perpetuate the Gender Pay Gap and Should be Ousted as a Factor Other Than Sex

By Torie Abbott Watkins. Full text here. Abstract: “When filling out job applications, employers routinely ask, “how much money did you make at your last job?” This discrete question has come under judicial scrutiny as women begin to find out one thing: they are making less money than their male counterparts based on their salary history…

Continue Reading

Note: Superfund and Tort Common Law: Why Courts Should Adopt a Contemporary Analytical Framework for Divisibility of Harm

By Joshua M. Greenberg. Full text here. Abstract: “This Note discusses the Supreme Court’s 2009 Burlington Northern decision and the impact that it had on divisibility defenses to cost recovery actions under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). It surveys the thirty-three post-Burlington Northern cases dealing with apportionment of harm and concludes that…

Continue Reading

Note: Recognizing Transgender, Intersex, and Nonbinary People in Healthcare Antidiscrimination Law

By Derek Waller. Full text here. Abstract: “Transgender people face frequent discrimination in healthcare by both providers and insurers. Insurers often deny them coverage for transition-related and routine “sex-specific” services. Even those who can access healthcare services struggle to find in-network physicians who will provide care in a way that respects their sexual and gender identity.…

Continue Reading

Note: Licensing Liability: Responding to Judicial Expansion of Antitrust Enforcement in North Carolina Dental

By Lesley E. Roe. Full text here. Abstract: “With the Supreme Court’s 2015 decision in North Carolina Dental v. FTC, the legal exposure of 1790 state occupational licensing boards expanded dramatically. In North Carolina Dental, the Supreme Court held that, under certain circumstances, state licensing boards are subject to the prohibitions of federal antitrust law. Licensing…

Continue Reading

Note: Late for an Appointment: Balancing Impartiality and Accountability in the IRS Office of Appeals

By David Hahn. Full text here. Abstract: “The Internal Revenue Service (“IRS”) Office of Appeals employs a cadre of individuals to preside over “collection due process” hearings. These hearings are meant to avoid litigation in the United States Tax Court by resolving disputes internally. “CDP officers” exercise significant authority and discretion over taxpayers’ cases, and…

Continue Reading

Note: I Get By with a Little Help from My 750-Dollar-Per-Tablet Friends: A Model Act for States to Prevent Dramatic Pharmaceutical Price Increases

Note: I Get By with a Little Help from My 750-Dollar-Per-Tablet Friends: A Model Act for States to Prevent Dramatic Pharmaceutical Price Increases By Alexander Walsdorf. Full Text Here. What can be done to prevent pharmaceutical companies from dramatically increasing the price of their drugs or other products? The past few years have seen multiple…

Continue Reading

Note: Mayo, Myriad, and a Muddled Analysis: Do Recent Changes to the Patentable Subject Matter Doctrine Threaten Patent Protections for Epigenetics-Based Inventions?

By Mike Sikora. Full text here In articulating the Mayo test for patentable subject matter under 35 U.S.C. § 101, the Supreme Court effectively replaced decades of judicial tests with a single streamlined analysis. Large-scale invalidations of software, business method, and communications patents swiftly followed, yet biotechnology patents have largely been spared. Even so, it may simply be…

Continue Reading